Tanya Lazor1, Leonie Tigelaar2, Jason D Pole3, Claire De Souza4, Deborah Tomlinson2, Lillian Sung2,5. 1. Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada. tanya.lazor@sickkids.ca. 2. Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada. 3. Pediatric Oncology Group of Ontario, 480 University Avenue, Toronto, ON, M5G 1V2, Canada. 4. Department of Psychiatry, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. 5. Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Abstract
PURPOSE: The primary objective was to describe anxiety measurement instruments used in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation (HSCT) and summarize their content and psychometric properties. METHODS: We conducted searches of MEDLINE, Embase, PsycINFO, HAPI, and CINAHL. We included studies that used at least one instrument to measure anxiety quantitatively in children or adolescents with cancer or undergoing HSCT. Two authors independently identified studies and abstracted study demographics and instrument characteristics. RESULTS: Twenty-seven instruments, 14 multi-item and 13 single-item, were used between 78 studies. The most commonly used instrument was the State-Trait Anxiety Inventory in 46 studies. Three multi-item instruments (Children's Manifest Anxiety Scale-Mandarin version, PROMIS Pediatric Anxiety Short Form, and the State-Trait Anxiety Inventory) and two single-item instruments (Faces Pain Scale-Revised and 10-cm Visual Analogue Scale, both adapted for anxiety) were found to be reliable and valid in children with cancer. CONCLUSIONS: We identified 14 different multi-item and 13 different single-item anxiety measurement instruments that have been used in pediatric cancer or HSCT. Only three multi-item and two single-item instruments were identified as being reliable and valid among pediatric cancer or HSCT patients and would therefore be appropriate to measure anxiety in this population.
PURPOSE: The primary objective was to describe anxiety measurement instruments used in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation (HSCT) and summarize their content and psychometric properties. METHODS: We conducted searches of MEDLINE, Embase, PsycINFO, HAPI, and CINAHL. We included studies that used at least one instrument to measure anxiety quantitatively in children or adolescents with cancer or undergoing HSCT. Two authors independently identified studies and abstracted study demographics and instrument characteristics. RESULTS: Twenty-seven instruments, 14 multi-item and 13 single-item, were used between 78 studies. The most commonly used instrument was the State-Trait Anxiety Inventory in 46 studies. Three multi-item instruments (Children's Manifest Anxiety Scale-Mandarin version, PROMIS Pediatric Anxiety Short Form, and the State-Trait Anxiety Inventory) and two single-item instruments (Faces Pain Scale-Revised and 10-cm Visual Analogue Scale, both adapted for anxiety) were found to be reliable and valid in children with cancer. CONCLUSIONS: We identified 14 different multi-item and 13 different single-item anxiety measurement instruments that have been used in pediatric cancer or HSCT. Only three multi-item and two single-item instruments were identified as being reliable and valid among pediatric cancer or HSCT patients and would therefore be appropriate to measure anxiety in this population.
Authors: Sean Phipps; Kelly E Buckholdt; Laly Fernandez; Lori Wiener; Mary Jo Kupst; Avi Madan-Swain; Larry Mullins; Rhonda Robert; Olle Jane Sahler; Nicole Vincent; Robert B Noll Journal: Pediatr Blood Cancer Date: 2011-01-31 Impact factor: 3.167
Authors: Darren A DeWalt; Heather E Gross; Debbie S Gipson; David T Selewski; Esi Morgan DeWitt; Carlton D Dampier; Pamela S Hinds; I-Chan Huang; David Thissen; James W Varni Journal: Qual Life Res Date: 2015-02-26 Impact factor: 4.147
Authors: Lidwine B Mokkink; Caroline B Terwee; Elizabeth Gibbons; Paul W Stratford; Jordi Alonso; Donald L Patrick; Dirk L Knol; Lex M Bouter; Henrica C W de Vet Journal: BMC Med Res Methodol Date: 2010-09-22 Impact factor: 4.615
Authors: Micol E Gianinazzi; Corina S Rueegg; Laura Wengenroth; Eva Bergstraesser; Johannes Rischewski; Roland A Ammann; Claudia E Kuehni; Gisela Michel Journal: Psychooncology Date: 2013-02-11 Impact factor: 3.894
Authors: Nils D Arvold; Terri S Armstrong; Katherine E Warren; Susan M Chang; Lisa M DeAngelis; Jaishri Blakeley; Marc C Chamberlain; Erin Dunbar; Herbert H Loong; David R Macdonald; David A Reardon; Michael A Vogelbaum; Ying Yuan; Michael Weller; Martin van den Bent; Patrick Y Wen Journal: Neuro Oncol Date: 2018-06-18 Impact factor: 12.300
Authors: Amy M Berkman; Karly M Murphy; Elizabeth J Siembida; Nancy Lau; Yimin Geng; Susan K Parsons; John M Salsman; Michael E Roth Journal: Value Health Date: 2021-08-08 Impact factor: 5.725
Authors: Henk J Arwert; Daniella M Oosterveer; Jan W Schoones; Caroline B Terwee; Thea P M Vliet Vlieland Journal: Arch Rehabil Res Clin Transl Date: 2022-03-25
Authors: Gomolemo Mahakwe; Ensa Johnson; Katarina Karlsson; Stefan Nilsson Journal: Int J Environ Res Public Health Date: 2021-02-16 Impact factor: 3.390